146 related articles for article (PubMed ID: 1721043)
21. The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?
Schofield L
Bull World Health Organ; 1990; 68 Suppl(Suppl):66-73. PubMed ID: 1709835
[TBL] [Abstract][Full Text] [Related]
22. Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes.
Chai SK; Clavijo P; Tam JP; Zavala F
J Immunol; 1992 Oct; 149(7):2385-90. PubMed ID: 1382101
[TBL] [Abstract][Full Text] [Related]
23. Evidence implicating MHC genes in the immunological nonresponsiveness to the Plasmodium falciparum CS protein.
Good MF; Kumar S; De Groot AS; Weiss WR; Quakyi IA; Dontfraid F; Smith GE; Cochran M; Berzofsky JA; Miller LH
Bull World Health Organ; 1990; 68 Suppl(Suppl):80-4. PubMed ID: 1709836
[TBL] [Abstract][Full Text] [Related]
24. Construction of synthetic immunogens: use of T- and B-cell epitopes of CS and RESA proteins of Plasmodium falciparum.
Ritu G; Rao DN
Vaccine; 1992; 10(11):761-5. PubMed ID: 1279906
[TBL] [Abstract][Full Text] [Related]
25. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth.
Chang SP; Gibson HL; Lee-Ng CT; Barr PJ; Hui GS
J Immunol; 1992 Jul; 149(2):548-55. PubMed ID: 1624802
[TBL] [Abstract][Full Text] [Related]
26. Distinct T cell specificities are induced with the authentic versus recombinant Plasmodium berghei circumsporozoite protein.
Krzych U; Jareed T; Link HT; Loomis LD; Ballou WR
J Immunol; 1992 Apr; 148(8):2530-8. PubMed ID: 1348519
[TBL] [Abstract][Full Text] [Related]
27. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides.
Partidos C; Stanley C; Steward M
Eur J Immunol; 1992 Oct; 22(10):2675-80. PubMed ID: 1382995
[TBL] [Abstract][Full Text] [Related]
28. Cross-reactions between idiotypes, Plasmodium falciparum derived peptides, dinitrophenyl and beta(2-->6) polyfructosan.
Daniel-Ribeiro C; Deslandes DC; Ferreira-Da-Cruz Mde F
J Clin Lab Immunol; 1991 Sep; 36(1):23-6. PubMed ID: 1668857
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the permissive association of a malaria T cell epitope with DR molecules.
Kilgus J; Jardetzky T; Gorga JC; Trzeciak A; Gillessen D; Sinigaglia F
J Immunol; 1991 Jan; 146(1):307-15. PubMed ID: 1701796
[TBL] [Abstract][Full Text] [Related]
30. Immune responses to the 18-kDa protein of Mycobacterium leprae. Similar B cell epitopes but different T cell epitopes seen by inbred strains of mice.
Doherty TM; Bäckström BT; Prestidge RL; Love SG; Harding DR; Watson JD
J Immunol; 1991 Mar; 146(6):1934-40. PubMed ID: 1706384
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.
Del Giudice G; Cheng Q; Mazier D; Berbiguier N; Cooper JA; Engers HD; Chizzolini C; Verdini AS; Bonelli F; Pessi A
Immunology; 1988 Feb; 63(2):187-91. PubMed ID: 2450833
[TBL] [Abstract][Full Text] [Related]
32. Peptide-primed CD4+ cells and malaria sporozoites.
Del Giudice G; Grillot D; Rénia L; Müller I; Corradin G; Louis JA; Mazier D; Lambert PH
Immunol Lett; 1990 Aug; 25(1-3):59-63. PubMed ID: 1704350
[TBL] [Abstract][Full Text] [Related]
33. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.
Birkett A; Lyons K; Schmidt A; Boyd D; Oliveira GA; Siddique A; Nussenzweig R; Calvo-Calle JM; Nardin E
Infect Immun; 2002 Dec; 70(12):6860-70. PubMed ID: 12438363
[TBL] [Abstract][Full Text] [Related]
34. Plasmodium berghei subunit vaccine: repeat synthetic peptide of circumsporozoite protein comprising T- and B-cell epitopes fails to confer immunity.
Migliorini P; Boulanger N; Betschart B; Corradin G
Scand J Immunol; 1990 Feb; 31(2):237-42. PubMed ID: 1689867
[TBL] [Abstract][Full Text] [Related]
35. Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.
Good MF; Maloy WL; Lunde MN; Margalit H; Cornette JL; Smith GL; Moss B; Miller LH; Berzofsky JA
Science; 1987 Feb; 235(4792):1059-62. PubMed ID: 2434994
[TBL] [Abstract][Full Text] [Related]
36. A synthetic vaccine constructed by copolymerization of B and T cell determinants.
Leclerc C; Przewlocki G; Schutze MP; Chedid L
Eur J Immunol; 1987 Feb; 17(2):269-73. PubMed ID: 2435562
[TBL] [Abstract][Full Text] [Related]
37. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria.
Zavala F; Tam JP; Hollingdale MR; Cochrane AH; Quakyi I; Nussenzweig RS; Nussenzweig V
Science; 1985 Jun; 228(4706):1436-40. PubMed ID: 2409595
[TBL] [Abstract][Full Text] [Related]
38. Antibodies raised against peptide fragments of bovine alpha s1-casein cross-react with the native protein, but recognize sites distinct from the determinants on the protein.
Shon DH; Enomoto A; Yamauchi K; Kaminogawa S
Eur J Immunol; 1991 Jun; 21(6):1475-80. PubMed ID: 1710568
[TBL] [Abstract][Full Text] [Related]
39. Conformational analysis of the immunodominant epitopes of the circumsporozoite protein of Plasmodium falciparum and knowlesi.
Fasman GD; Park K; Schlesinger DH
Biopolymers; 1990 Jan; 29(1):123-30. PubMed ID: 1691663
[TBL] [Abstract][Full Text] [Related]
40. Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination.
Valmori D; Pessi A; Bianchi E; Corradin G
J Immunol; 1992 Jul; 149(2):717-21. PubMed ID: 1378079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
